tiprankstipranks
Capricor Therapeutics (CAPR)
NASDAQ:CAPR

Capricor Therapeutics (CAPR) Financial Statements

649 Followers

Capricor Therapeutics Financial Overview

Capricor Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.875; its P/E ratio is -5.51; Capricor Therapeutics is scheduled to report earnings on August 8, 2024, and the estimated EPS forecast is $-0.36. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 4.91M$ 12.09M$ 6.19M$ 3.92M$ 2.99M
Gross Profit$ 4.91M$ 12.09M$ 6.19M$ 3.92M-
EBIT$ -9.79M$ -721.92K$ -6.36M$ -7.35M$ -7.81M
EBITDA$ -9.46M$ -414.31K$ -6.09M$ -7.09M$ -7.58M
Net Income Common Stockholders$ -9.79M$ -762.10K$ -6.36M$ -7.37M$ -7.81M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 39.92M$ 39.49M$ 28.52M$ 37.79M$ 45.17M
Total Assets$ 49.44M$ 58.73M$ 37.15M$ 45.98M$ 53.86M
Total Debt$ 5.40M$ 5.61M$ 5.79M$ 5.60M$ 5.77M
Net Debt$ -34.52M$ -33.88M$ -22.73M$ -32.19M$ -39.40M
Total Liabilities$ 31.01M$ 36.13M$ 38.94M$ 43.28M$ 47.66M
Stockholders Equity$ 18.43M$ 22.60M$ -1.79M$ 2.73M$ 6.21M
Cash Flow-
Free Cash Flow$ -1.88M$ -12.15M$ -9.06M$ -9.55M$ 3.86M
Operating Cash Flow$ -1.27M$ -11.59M$ -8.79M$ -9.42M$ 4.21M
Investing Cash Flow$ -9.50M$ -5.86M$ 7.72M$ 6.46M$ -3.21M
Financing Cash Flow$ 2.29M$ 23.17M$ 221.08K$ 2.19M$ 3.90K
Currency in USD

Capricor Therapeutics Earnings and Revenue History

Capricor Therapeutics Debt to Assets

Capricor Therapeutics Cash Flow

Capricor Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis